| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |